When Alex Balmes turned 31, he felt tired all the time. He put it down to getting older and being a new dad. But when he ...
Abbott recalls glucose sensors linked to 7 deaths and 860 serious injuries; FDA urges discontinuation of specific FreeStyle Libre 3 models.
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
Omnipod 5 is indicated for individuals aged two years and older with type 1 diabetes and compatible with the Abbott FreeStyle Libre 2 Plus sensor and the Dexcom G7 sensor in Saudi Arabia, Kuwait, and ...
In people without diabetes, the body makes insulin in the pancreas, and it travels straight to the liver. But when insulin is ...
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...
In 2025, New York state and federal courts issued a series of consequential decisions shaping the litigation landscape for pharmaceutical, ...
Type 1 diabetes is the most common type of diabetes in young people. It happens when — for reasons not yet fully understood — the body turns on itself and destroys the cells that produce the ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.
Beneficiaries of Medicare and Medicare Advantage can now obtain the MiniMed 780G system combined with the Instinct sensor.
We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results